Home Events Event Articles HTA
 

Patient Video Diaries

ipposi_video_t
IPPOSI have asked people to describe to the public what life is like living with a rare disease in Ireland.

Upcoming Events

No events

Events Calendar

« < May 2012 > »
M T W T F S S
30 1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 31 1 2 3
HTA PDF Print E-mail
Tuesday, 22 March 2011 12:08

MEMBER ONLY EVENT - REGISTRATION REQUIRED


IPPOSI Information Day on Health Technology Assessment for Pharmaceuticals and New Medical Technologies - Where are we now?

TUESDAY 5TH APRIL 2011

EUROPEAN UNION HOUSE, Molesworth Street, D2.

11am – 2pm


Over the last decade innovative medicines and new health technologies have contributed to significant improvements in health status and quality of life. All across Europe people are living longer. In Ireland on average people are living into their seventies and eighties and, as a result, are spending a higher percentage of their lives in close contact with the health system. Treatments are also improving while becoming more expensive and resources to pay for such treatments are not increasing. These changes are putting our health system under increasing pressure.

 

This Information Day is an attempt to follow on from our Access to Medicines meeting held in 2008 where IPPOSI recommended the following:

 

· Ireland needs to foster a consensus based approach to the development of HTAs/PEAs rather than a prescriptive approach.

· The scope of HTA/PEA should not be limited to economic considerations only. Social, ethical, legal considerations are equally important.

· Patients and patient organisations need to be assisted and empowered to better understand HTA/PEA system and to formally engage in the HTA/PEA process.

 

SPEAKERS:

 

Ms Mairin Ryan, HIQA – outlining the HTA system in Ireland and the current structure in place

Prof Ciaran O’Neill, NUI Galway – the academic perspective with a particular focus on HTA’s and Medical Devices

Ms Jenny Hughes, GSK – the industry perspective in the context of access and new pharmaceuticals

Ms Liuska Sanna, European Patients’ Forum – the patient’s perspective, a look at Europe and patient involvement in the HTA process

Ms Orlagh Murphy, Enterprise Ireland – outlining EI’s role in guiding companies through the system in Ireland

Register to attend by contacting: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

 

Places only open to IPPOSI members at present, if you wish to become a member contact: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

 

Industry Fee: €50

Science & Patient Groups: Free